FDA's Gottlieb eyes PBM consolidation impact on generic entry-CNBC
Reuters NEW YORK, March 28 (Reuters) - The head of the U.S. Food & Drug Administration Scott Gottlieb said on Wednesday that he was concerned about the impact of deals like the CVS Health purchase of Aetna Inc on the ability of pharmaceutical companies to ... |
from Health - Google News https://ift.tt/2E1SRHq
EmoticonEmoticon